TrialJAMA2016

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Robert W Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.